TY - JOUR
T1 - Influence of maternal obesity on the association between common pregnancy complications and risk of childhood obesity
T2 - an individual participant data meta-analysis
AU - Patro Golab, Bernadeta
AU - Santos, Susana
AU - Voerman, Ellis
AU - Lawlor, Debbie A.
AU - Jaddoe, Vincent W.V.
AU - Gaillard, Romy
AU - Patro Golab, Bernadeta
AU - Santos, Susana
AU - Voerman, Ellis
AU - Barros, Henrique
AU - Bergström, Anna
AU - Charles, Marie Aline
AU - Chatzi, Leda
AU - Chevrier, Cécile
AU - Chrousos, George P.
AU - Corpeleijn, Eva
AU - Costet, Nathalie
AU - Crozier, Sarah
AU - Devereux, Graham
AU - Eggesbø, Merete
AU - Ekström, Sandra
AU - Fantini, Maria P.
AU - Farchi, Sara
AU - Forastiere, Francesco
AU - Georgiu, Vagelis
AU - Godfrey, Keith M.
AU - Gori, Davide
AU - Hanke, Wojciech
AU - Hertz-Picciotto, Irva
AU - Heude, Barbara
AU - Hryhorczuk, Daniel
AU - Inskip, Hazel
AU - Ibarluzea, Jesus
AU - Kenny, Louise C.
AU - Küpers, Leanne K.
AU - Lagström, Hanna
AU - Lehmann, Irina
AU - Lenters, Virissa
AU - Llop, Sabrina Llop
AU - Magnus, Per
AU - Majewska, Renata
AU - Mäkelä, Johanna
AU - Manios, Yannis
AU - McAuliffe, Fionnuala M.
AU - McDonald, Sheila W.
AU - Mehegan, John
AU - Mommers, Monique
AU - Morgen, Camilla S.
AU - Smit, Henriette A.
AU - van Rossem, Lenie
N1 - Funding Information:
The lead authors received funding from the EU's Horizon 2020 research and innovation programme under grant agreement number 733206 (LifeCycle). Cohort-specific and individual funding is given in the appendix . We gratefully acknowledge participants from all cohorts involved in this study.
Funding Information:
BPG received a research training fellowship grant from the Nestle Nutrition Institute. DAL has received support from Roche Diagnostics and Medtronic in relation to biomarker research that is not related to the research presented in this Article. All other authors declare no competing interests.
Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Background: Gestational diabetes and gestational hypertensive disorders are associated with offspring obesity, but the role of maternal adiposity in these associations remains unclear. We aimed to investigate whether these pregnancy complications affect the odds of offspring obesity independently of maternal obesity. Methods: We did an individual participant data (IPD) meta-analysis of mother–offspring pairs from prospective birth cohort studies that had IPD on mothers with singleton liveborn children born from 1989 onwards and had information available about maternal gestational diabetes, gestational hypertension or pre-eclampsia, and childhood body-mass index (BMI). We applied multilevel mixed-effects models to assess associations of gestational diabetes, gestational hypertension, and pre-eclampsia with BMI SD scores and the odds of overweight and obesity throughout childhood, adjusting for lifestyle characteristics (offspring's sex, maternal age, educational level, ethnicity, parity, and smoking during pregnancy). We then explored the extent to which any association was explained by maternal pre-pregnancy or early-pregnancy BMI. Findings: 160 757 mother–offspring pairs from 34 European or North American cohorts were analysed. Compared with uncomplicated pregnancies, gestational diabetes was associated with increased odds of overweight or obesity throughout childhood (odds ratio [OR] 1·59 [95% CI 1·36 to 1·86] for early childhood [age 2·0–4·9 years], 1·41 [1·26 to 1·57] for mid childhood [5·0–9·9 years], and 1·32 [0·97 to 1·78] for late childhood [10·0–17·9 years]); however, these associations attenuated towards the null following adjustment for maternal BMI (OR 1·35 [95% CI 1·15 to 1·58] for early childhood, 1·12 [1·00 to 1·25] for mid childhood, and 0·96 [0·71 to 1·31] for late childhood). Likewise, gestational hypertension was associated with increased odds of overweight throughout childhood (OR 1·19 [95% CI 1·01 to 1·39] for early childhood, 1·23 [1·15 to 1·32] for mid childhood, and 1·49 [1·30 to 1·70] for late childhood), but additional adjustment for maternal BMI largely explained these associations (1·01 [95% CI 0·86 to 1·19] for early childhood, 1·02 [0·95 to 1·10] for mid childhood, and 1·18 [1·03 to 1·36] for late childhood). Pre-eclampsia was associated with decreased BMI in early childhood only (difference in BMI SD score −0·05 SD score [95% CI −0·09 to −0·01]), and this association strengthened following additional adjustment for maternal BMI. Interpretation: Although lowering maternal risk of gestational diabetes, gestational hypertension, and pre-eclampsia is important in relation to maternal and fetal pregnancy outcomes, such interventions are unlikely to have a direct impact on childhood obesity. Preventive strategies for reducing childhood obesity should focus on maternal BMI rather than on pregnancy complications. Funding: EU's Horizon 2020 research and innovation programme (LifeCycle Project).
AB - Background: Gestational diabetes and gestational hypertensive disorders are associated with offspring obesity, but the role of maternal adiposity in these associations remains unclear. We aimed to investigate whether these pregnancy complications affect the odds of offspring obesity independently of maternal obesity. Methods: We did an individual participant data (IPD) meta-analysis of mother–offspring pairs from prospective birth cohort studies that had IPD on mothers with singleton liveborn children born from 1989 onwards and had information available about maternal gestational diabetes, gestational hypertension or pre-eclampsia, and childhood body-mass index (BMI). We applied multilevel mixed-effects models to assess associations of gestational diabetes, gestational hypertension, and pre-eclampsia with BMI SD scores and the odds of overweight and obesity throughout childhood, adjusting for lifestyle characteristics (offspring's sex, maternal age, educational level, ethnicity, parity, and smoking during pregnancy). We then explored the extent to which any association was explained by maternal pre-pregnancy or early-pregnancy BMI. Findings: 160 757 mother–offspring pairs from 34 European or North American cohorts were analysed. Compared with uncomplicated pregnancies, gestational diabetes was associated with increased odds of overweight or obesity throughout childhood (odds ratio [OR] 1·59 [95% CI 1·36 to 1·86] for early childhood [age 2·0–4·9 years], 1·41 [1·26 to 1·57] for mid childhood [5·0–9·9 years], and 1·32 [0·97 to 1·78] for late childhood [10·0–17·9 years]); however, these associations attenuated towards the null following adjustment for maternal BMI (OR 1·35 [95% CI 1·15 to 1·58] for early childhood, 1·12 [1·00 to 1·25] for mid childhood, and 0·96 [0·71 to 1·31] for late childhood). Likewise, gestational hypertension was associated with increased odds of overweight throughout childhood (OR 1·19 [95% CI 1·01 to 1·39] for early childhood, 1·23 [1·15 to 1·32] for mid childhood, and 1·49 [1·30 to 1·70] for late childhood), but additional adjustment for maternal BMI largely explained these associations (1·01 [95% CI 0·86 to 1·19] for early childhood, 1·02 [0·95 to 1·10] for mid childhood, and 1·18 [1·03 to 1·36] for late childhood). Pre-eclampsia was associated with decreased BMI in early childhood only (difference in BMI SD score −0·05 SD score [95% CI −0·09 to −0·01]), and this association strengthened following additional adjustment for maternal BMI. Interpretation: Although lowering maternal risk of gestational diabetes, gestational hypertension, and pre-eclampsia is important in relation to maternal and fetal pregnancy outcomes, such interventions are unlikely to have a direct impact on childhood obesity. Preventive strategies for reducing childhood obesity should focus on maternal BMI rather than on pregnancy complications. Funding: EU's Horizon 2020 research and innovation programme (LifeCycle Project).
UR - http://www.scopus.com/inward/record.url?scp=85055054360&partnerID=8YFLogxK
U2 - 10.1016/S2352-4642(18)30273-6
DO - 10.1016/S2352-4642(18)30273-6
M3 - Article
C2 - 30201470
AN - SCOPUS:85055054360
SN - 2352-4642
VL - 2
SP - 812
EP - 821
JO - The Lancet Child and Adolescent Health
JF - The Lancet Child and Adolescent Health
IS - 11
ER -